1. Home
  2. VWAVW vs VRXAW Comparison

VWAVW vs VRXAW Comparison

Compare VWAVW & VRXAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VisionWave Holdings Inc. Warrant

VWAVW

VisionWave Holdings Inc. Warrant

N/A

Current Price

$0.07

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Logo Veraxa Biotech AG Warrants

VRXAW

Veraxa Biotech AG Warrants

N/A

Current Price

$0.10

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VWAVW
VRXAW
Founded
2024
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
VWAVW
VRXAW
Price
$0.07
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.6K
22.6K
Earning Date
08-27-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.07
52 Week High
$4.24
$0.23

Technical Indicators

Market Signals
Indicator
VWAVW
VRXAW
Relative Strength Index (RSI) 29.55 40.17
Support Level N/A $0.07
Resistance Level $0.28 $0.12
Average True Range (ATR) 0.03 0.01
MACD 0.01 0.00
Stochastic Oscillator 2.28 23.98

Price Performance

Historical Comparison
VWAVW
VRXAW

About VWAVW VisionWave Holdings Inc. Warrant

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

About VRXAW Veraxa Biotech AG Warrants

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: